Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-26

Clinical Trial Update: Effect of Liraglutide on Clock Genes [NA]

View source ↗

Summary

A Tel Aviv University study investigates the effect of liraglutide on clock (circadian) genes in individuals with type 2 diabetes; phase and status are not prov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Victoza (Liraglutide)

Snippet

Sponsor: Tel Aviv University | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN